February 19, 2012
Kettering Medical Center has realized a positive financial impact of $3.7 million in the past year as the result of a change in standard operating proceures using a new innovative testing technology that diagnoses a wide variety of infectious diseases faster and more accurately than traditional testing.
"This unique diagnostic technology allows us to diagnose patients faster, and the faster we can provide treatment the faster our patients heal," said Carol Quinter, Ph.D., Director of Kettering Laboratory Clinical Services and Technical Director of DIATHERIX Laboratory at Kettering Medical Center. "This technology, developed by DIATHERIX Laboratories, is a game changer for the healthcare industry. Hospital savings are directly tied to reducing patient infection rates, decreasing the days patients need to be kept in isolation and prescribing fewer antibiotics."
To read the rest of the release from PR Newswire, click here.